CapsoVision, Inc. Common Stock (CV) support and resistance · rev $3.5M
CapsoVision, Inc. Common Stock (CV) is a medical devices company listed on US.
This page maps CapsoVision, Inc. Common Stock (CV) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CV revenue for 2025-09-30 was $3.5M. Net income was -$7.9M. Revenue was up 6.7% from 2025-06-30 to 2025-09-30. CV currently screens at market cap $359.2M.
CV currently screens at market cap $359.2M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CV 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CV quote page for the session range and the stock page for the full model.
Not investment advice.